Ismail Abdul Fattah Agrees to Become CytoDyn's Senior Advisor of Business Development for the Middle East

LUTZ, Fla. - Thursday, January 19th 2012 [ME NewsWire]

(BUSINESS WIRE)-- CytoDyn Inc. (the "Company") (OTC QB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, and other antibody applications, announced today that Ismail Abdul Fattah will serve as the Company's Senior Advisor of Business Development for the Middle East. Mr. Fattah will continue to serve in his role with AM Financials s.a.l, in Beirut, Lebanon. As part of the Company's evolution and international business development activities, Mr. Fattah will work in conjunction with Dr. Nadar Pourhassan, the Company's Managing Director of Business Development, to expand the Company's business development activities in the Middle East.

"The Company is pleased and honored to have Mr. Fattah advising on sponsorship and business development opportunities in the Middle East," commented Kenneth J. Van Ness, President and Chief Executive Officer of the Company.

"I am optimistic that my experience will complement the Company as it progresses its scientific and business opportunities in the Middle East, and I look forward to expanding our relationship in the future," commented Mr. Fattah.

Forward Looking Statements

The Press Release includes forward-looking statements and includes forward-looking information within the meaning of United States securities laws. These statements and this information represent the Company’s intentions, plans, expectations and beliefs, and are subject to risks, uncertainties and other factors, of which many are beyond the Company’s control. These factors could cause actual results to differ materially from such forward-looking statements or forward-looking information. The words "believe," "estimate," "expect," "intend," "attempt," "anticipate," "foresee," "plan," and similar expressions and variations thereof, identify certain of such forward-looking statements or forward-looking information, which speak only as of the date on which they are made. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements or forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements or on this forward-looking information.

Contacts

CytoDyn Inc.

Douglas E. Jacobson

Controller

813-527-6969